We work with bio-medical companies in all fields:
Medical device companies, Pharmaceutical companies,
medical and biological research companies and individual researchers.
Oxitone Medical Receives FDA Clearance for Wrist-Sensor Pulse Oximetry Bracelet
Medical device and digital health startup Oxitone Medical launches the first to market wrist-sensor pulse oximetry bracelet to transform delivery of chronic disease home care.
Oxitone Medical (Oxitone), an Israeli-based medical device and digital health company developing wearable monitoring solutions to transform delivery of chronic disease home care, has received 510(k) clearance from the FDA for its wrist-sensor pulse oximetry bracelet Oxitone 1000. The wrist-sensor pulse oximeter Oxitone 1000 measures critical vital signs such as SpO2 and pulse rate with the same precision as conventional fingertip pulse oximeters. Oxitone 1000 becomes the first to market a wrist-sensor pulse oximeter that offers comfortable real-time monitoring with high patient compliance.
The Oxitone solution has been validated in pilot studies in a number of medical settings including desaturation labs. The results have proven almost 100% patient satisfaction, significant reduction of medical staff workload and a potential for major reduction in readmission. Oxitone FDA clearance paves the way towards supervision of patients beyond hospital walls while providing the hospital’s medical-grade level of care.
About Oxitone Medical Ltd.
Oxitone is an Israeli-based medical device and digital health company focused on developing cutting edge wearable and digital medical technologies for medical systems, clinics, nursing homes, telemedicine companies, payers and providers. The flagship product is the world’s first FDA-approved wrist-sensor pulse oximetry bracelet Oxitone 1000. The company is a participant in StartUp Health and Texas Medical Center (TMCx) startup accelerator programs.
For more information, please visit: http://www.oxitone.com